DM

Dhruva Manbahadur Pradhan

Active Director Director DIN 00818499
DIN 00818499 First appointment Aug 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Aug 2011
Shareholding value •••• Premium profile

About Dhruva Manbahadur Pradhan

Data last updated:

Dhruva Manbahadur Pradhan is a Director at Eclat Pharma And Aerosols Pvt Ltd (since 2021), Director at Ultra Aero Products Private Limited (since 2021) and Director at Wellnesstrove Healthcare Private Limited (since 2024). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹10.71 Cr; the largest is Eclat Pharma And Aerosols Pvt Ltd at ₹9.94 Cr (FY 2025). Earlier, Dhruva Manbahadur Pradhan was a Director at Novitus Health Care Private Limited (from 2011).

DIN 00818499
Primary Designation Director
Industry Healthcare
First Appointment 23 Aug 2011
Oldest Company Age 35 yrs
Largest company Eclat Pharma And Aerosols Pvt Ltd · ₹9.94 Cr (FY 2025)
Combined revenue ₹10.71 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eclat Pharma And Aerosols Pvt Ltd U24239MH1991PTC062241
Director23 Nov 20211991₹9.94 Cr (FY 2025)Active
Ultra Aero Products Private Limited U99999MH1997PTC105480
Director23 Nov 20211997₹76.8 Lakh (FY 2025)Active
Director21 Nov 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Novitus Health Care Private Limited U51909MH2011PTC221168
Director23 Aug 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eclat Pharma And Aerosols Pvt Ltd
Novitus Health Care Private Limited
Ultra Aero Products Private Limited
Wellnesstrove Healthcare Private Limited
Premium access

Shareholding and investment profile for Dhruva Manbahadur Pradhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhruva Manbahadur Pradhan

Dhruva Manbahadur Pradhan currently holds 3 directorships: Eclat Pharma And Aerosols Pvt Ltd (Director, since 23 Nov 2021, revenue ₹9.94 Cr (FY 2025)); Ultra Aero Products Private Limited (Director, since 23 Nov 2021, revenue ₹76.8 Lakh (FY 2025)); Wellnesstrove Healthcare Private Limited (Director, since 21 Nov 2024).

Dhruva Manbahadur Pradhan was first appointed on 23 Aug 2011 as Director at Novitus Health Care Private Limited. The most recent appointment on record is 21 Nov 2024 at Wellnesstrove Healthcare Private Limited.

The 2 current companies of Dhruva Manbahadur Pradhan that report revenue have a combined latest revenue of ₹10.71 Cr: Eclat Pharma And Aerosols Pvt Ltd ₹9.94 Cr (FY 2025); Ultra Aero Products Private Limited ₹76.8 Lakh (FY 2025).

Dhruva Manbahadur Pradhan held 1 earlier board appointment: Novitus Health Care Private Limited (Director, from 23 Aug 2011).

The current boards of Dhruva Manbahadur Pradhan's companies include Abhishek Dhruva Pradhan (Eclat Pharma And Aerosols Pvt Ltd), Chetna Dhruva Pradhan (Eclat Pharma And Aerosols Pvt Ltd), Urvashi Dhruva Pradhan (Eclat Pharma And Aerosols Pvt Ltd), Ravikant Shankaragoud Patil (Ultra Aero Products Private Limited), Anil Ganesh Kamath (Wellnesstrove Healthcare Private Limited), Malini Thakur (Wellnesstrove Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available